Bookbuilding IPO | ₹3,043 Cr | Listed at BSE, NSE | Wed, Dec 11, 2024 - Fri, Dec 13, 2024
Sai Life Sciences IPO is a book build issue of ₹3,042.62 crores. The issue is a combination of fresh issue of 1.73 crore shares aggregating to ₹950.00 crores and offer for sale of 3.81 crore shares aggregating to ₹2,092.62 crores.
Sai Life Sciences IPO bidding started from Dec 11, 2024 and ended on Dec 13, 2024. The allotment for Sai Life Sciences IPO was finalized on Dec 16, 2024. The shares got listed on BSE, NSE on Dec 18, 2024.
Sai Life Sciences IPO price band is set at ₹549 per share. The lot size for an application is 27. The minimum amount of investment required by an retail is ₹14,823 (27 shares) (based on upper price). The lot size investment for sNII is 14 lots (378 shares), amounting to ₹2,07,522, and for bNII, it is 68 lots (1,836 shares), amounting to ₹10,07,964.
Kotak Mahindra Capital Co.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Sai Life Sciences IPO RHP for detailed Information.
IPO Open
Wed, Dec 11, 2024
IPO Close
Fri, Dec 13, 2024
Issue Price
₹549 per share
Market Cap (Pre-IPO)
₹11,418.63 Cr
| IPO Date | 11 to 13 Dec, 2024 |
| Listed on | Wed, Dec 18, 2024 |
| Face Value | ₹1 per share |
| Price Band | ₹522 to ₹549 |
| Issue Price | ₹549 per share |
| Lot Size | 27 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 5,54,21,123 shares (agg. up to ₹3,043 Cr) |
| Fresh Issue | 1,73,04,189 shares (agg. up to ₹950 Cr) |
| Offer for Sale | 3,81,16,934 shares of ₹1 (agg. up to ₹2,093 Cr) |
| Share Holding Pre Issue | 19,06,85,340 shares |
| Share Holding Post Issue | 20,79,89,529 shares |
| BSE Script Code / NSE Symbol | 544306 / SAILIFE |
| ISIN | INE570L01029 |
Sai Life Sciences IPO offers total 5,54,21,123 shares. Out of which 2,77,10,560 (50.00%) allocated to QIB, 1,10,84,224 (20.00%) allocated to QIB (Ex- Anchor), 83,13,169 (15.00%) allocated to NII 1,93,97,394 (35.00%) allocated to RII and 1,66,26,336 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 2,77,10,560 (50.00%) | NA |
| − Anchor Investor Shares Offered | 1,66,26,336 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 1,10,84,224 (20.00%) | NA |
| NII (HNI) Shares Offered | 83,13,169 (15.00%) | NA |
| − bNII > ₹10L | 55,42,113 (10.00%) | 14,661 |
| − sNII < ₹10L | 27,71,056 (5.00%) | 7,330 |
| Retail Shares Offered | 1,93,97,394 (35.00%) | 7,18,422 |
| Total Shares Offered | 5,54,21,123 (100.00%) |
Investors can bid for a minimum of 27 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹1,92,699 |
| S-HNI (Min) | 14 | 378 | ₹2,07,522 |
| S-HNI (Max) | 67 | 1,809 | ₹9,93,141 |
| B-HNI (Min) | 68 | 1,836 | ₹10,07,964 |
Sai Life Sciences IPO raises ₹912.79 crore from anchor investors. Sai Life Sciences IPO Anchor bid date is December 10, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Tue, Dec 10, 2024 |
| Shares Offered | 1,66,26,336 |
| Anchor Portion (₹ Cr.) | 912.79 |
| Anchor lock-in period end date for 50% shares (30 Days) | Tue, Jan 14, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Sat, Mar 15, 2025 |
Incorporated in January 1999, Sai Life Sciences Limited researches, develops, and manufactures small-molecule new chemical entities. The company offers tailor-made services to biotech firms and global pharma companies.
In the Financial Year 2024 and for the month ending September 30, 2024, the company provided services to over 280 innovator pharmaceutical companies, including more than 230 in that month alone. Among these clients, the company worked with 18 of the top 25 pharmaceutical companies based on their revenue in the calendar year 2023.The services were offered across countries such as the US, the UK, Europe, and Japan.
The company's business development team consists of 16 experienced and qualified professionals, with six located in the US, nine in the UK and Europe, and one in Japan.
The company has the following service offerings.
As of September 30, 2024, the company had 2,353 scientific staff, with the majority of the scientific team holding advanced degrees, including 302 Ph. D.s and 1,475 master’s degrees.
As of September 30, 2024, the company had 3135 employees with capabilities across the CRDMO value chain.
Competitive Strength:
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Total Income | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax | 28.01 | 82.81 | 9.99 | 6.23 |
| NET Worth | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Reserves and Surplus | 1,025.44 | 953.99 | 867.43 | 859.17 |
| Total Borrowing | 764.49 | 710.16 | 699.23 | 751.32 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company | 720.00 |
| 2 | General corporate purposes | 198.98 |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 11.79% |
| ROCE | 15.96% |
| RoNW | 8.13% |
| PAT Margin | 5.65% |
| Price to Book Value | 10.18 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 4.34 | 2.69 |
| P/E (x) | 126.42 | 203.82 |
| Promoter Holding | 41.82% | 35.24% |
| Market Cap | ₹11,418.63 Cr. |
The Sai Life Sciences IPO is subscribed 10.27 times on December 13, 2024 6:19:09 PM (Day 3). The public issue subscribed 1.39 times in the retail category, 29.78 times in the QIB category, and 4.99 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 29.78 | 1,10,84,225 | 33,01,25,058 |
| NII | 4.99 | 83,13,168 | 4,15,22,058 |
| bNII (bids above ₹10L) | 6.1 | 55,42,113 | 3,38,13,693 |
| sNII (bids below ₹10L) | 2.78 | 27,71,056 | 77,08,365 |
| Retail | 1.39 | 1,93,97,392 | 2,69,12,493 |
| Total | 10.27 | 3,87,94,785 | 39,85,59,609 |
Total Application : 6,46,482
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLM's fees (including brokerage and selling commission) | 72.99 |
| 2 | Commission/processing fee for SCSBs, Sponsor Banks and Bankers to the Offer. Brokerage and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 8.83 |
| 3 | Fees payable to Registrar to the Offer | |
| 4 | Fees payable to the other parties to the Offer, including Statutory Auditors, Independent Chartered Accountant, industry expert, and fees payable to legal counsel | 28.60 |
| 5 | Advertising and marketing expenses for the Offer | 6.71 |
| 6 | Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | 7.49 |
| 7 | Printing and stationery | 3.03 |
| 8 | Miscellaneous | 0.83 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹549.00 | ₹549.00 |
| Open | ₹660.00 | ₹650.00 |
| Low | ₹651.20 | ₹650.00 |
| High | ₹787.35 | ₹780.00 |
| Last Trade | ₹765.30 | ₹764.65 |
Lead Manager Reports
Sai Life Sciences IPO is a main-board IPO of 5,54,21,123 equity shares of the face value of ₹1 aggregating up to ₹3,043 Crores. The issue is priced at ₹549 per share. The minimum order quantity is 27.
The IPO opens on Wed, Dec 11, 2024, and closes on Fri, Dec 13, 2024.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Sai Life Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Sai Life Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sai Life Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sai Life Sciences IPO opens on Wed, Dec 11, 2024 and closes on Fri, Dec 13, 2024.
Sai Life Sciences IPO lot size is 27, and the minimum amount required for application is ₹14,823.
You can apply in Sai Life Sciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sai Life Sciences IPO will be done on Monday, December 16, 2024, and the allotted shares will be credited to your demat account by Tue, Dec 17, 2024. Check the Sai Life Sciences IPO allotment status.
The Sai Life Sciences IPO listing date is on Wed, Dec 18, 2024.
